
FOXO4-DRI 10mg
For Research Use Only (RUO) · Read our research disclaimer
Lowest price in the last 30 days: €139.00
- COA for every batchPurity >99.8% · Content 11.08 mg · HPLC + LC-MSPDF
- Shipped with tracking on the business day of paymentfrom the EU warehouse · 2–6 business days · no customs
- EU shipping guaranteeParcel lost? We reship free of charge
Ordering information
For bank transfers, use the amount and payment reference in your order confirmation. An order is paid only once receipt of payment is confirmed.
Check delivery coverage, shipping costs and delivery times. Review availability and preorder notices for the selected variant.
For qualified laboratory research only (RUO). Not for use in humans or animals.

Frequently asked questions
What is FOXO4-DRI?
FOXO4-DRI is a D-amino acid retro-inverso peptide designed to disrupt the p53–FOXO4 interaction in senescent cells. It was originally described by de Keizer's group (Nature 2017) and serves as a reference tool in senolytics research.
Why D-Retro-Inverso?
D-amino acids in a retro-inverso sequence retain the spatial orientation of side chains but are largely stable against proteases, which significantly extends in vitro half-life and bioavailability in cell assays.
Which endpoints are investigated in FOXO4-DRI studies?
Typical in vitro endpoints include SA-β-Galactosidase activity, p21^CIP1 expression, γH2AX foci, SASP cytokine profiles (IL-6, IL-8, MMP-3), and p53 nucleolus/cytoplasm translocation in senescent cell models.
Is FOXO4-DRI the same as Proxofim?
Proxofim is the trade name given by a startup to a FOXO4-DRI analog. FOXO4-DRI refers to the peptide sequence itself, as described in de Keizer et al. (Nature 2017). NovaCell provides the peptide exclusively as an RUO reference tool.
Is FOXO4-DRI intended for use in humans?
No. FOXO4-DRI from NovaCell is strictly for Research Use Only and is not approved for therapeutic or diagnostic applications.
Batch record: every lab report
Every batch is analysed before it is sold. These are all published reports for this product – with report number, date and a PDF you can check.
| Batch | Report no. | Date | Purity (HPLC) | Endotoxin | Lab | |
|---|---|---|---|---|---|---|
| FX-082604 | Lyo-0826 | Sep 2026 | >99.8% | – | Liquilabs |
Analyses by external, independent testing laboratories (Liquilabs). Every report has its own analysis number and can be viewed as a PDF or on the lab's verification page.
Supplier: NCBL Sciences OÜ (Estonia), registry code 17455124 · shipped from our EU warehouse in Poland.
All products strictly for research and laboratory use (RUO).
Related research peptides
Peptides from the same research category – HPLC + LC-MS tested, with COA.
Related context
Deepen the topic with matching comparisons, related peptides and trust resources.
Related peptides
Cellular Ageing & Mitochondrial Peptides
Context & trust
Quality, shipping and RUO compliance at a glance.


